Anti-GD2 IgA kills tumors by neutrophils without antibody-associated pain in the preclinical treatment of high-risk neuroblastoma

QR Code

Anti-GD2 IgA kills tumors by neutrophils without antibody-associated pain in the preclinical treatment of high-risk neuroblastoma

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Stefan Nierkens, Niels Eijkelkamp, Maaike Nederend, Jeanette Leusen, Mitchell Evers, Marjolein Stip, Kaylee Keller, Hanneke Willemen, Marco Jansen, Chilam Chan, Kevin Budding, Thomas Valerius, Friederike Meyer-Wentrup
Format:	article
Langue:	EN
Publié:	BMJ Publishing Group 2021
Sujets:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/22ca94048a6c4dd2acf901975662eb6e
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma
par: Babak Moghimi, et autres
Publié: (2021)

Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastoma
par: Nicola Tumino, et autres
Publié: (2021)

A Novel pH-Sensitive Multifunctional DNA Nanomedicine: An Enhanced and Harmless GD2 Aptamer-Mediated Strategy for Guiding Neuroblastoma Antitumor Therapy
par: Zhang L, et autres
Publié: (2021)

Internal dose assessment of 148Gd using isotope ratios of gamma-emitting 146Gd or 153Gd in accidently released spallation target particles
par: C. Rääf, et autres
Publié: (2020)

Neuroblastoma
par: Fuentes,Luis, et autres
Publié: (1976)

IgA pemphigus showing IgA antibodies to desmoglein 1 and 3
par: Salama Hegazy, et autres
Publié: (2016)

Deficiencia de IgA
par: SORENSEN D,RICARDO
Publié: (1973)

PARATESTICULAR INVOLVEMENT IN NEUROBLASTOMA
par: Volkan KÖSE, et autres
Publié: (2021)

NEPHRITOGENIC ACTIVITY OF IgA-BINDING STREPTOCOCCUS PYOGENES: AN EXPERIMENTAL MODEL OF IgA GLOMERULONEPHRITIS
par: L. A. Burova, et autres
Publié: (2016)

Abdominal radiotherapy: a major determinant of metabolic syndrome in nephroblastoma and neuroblastoma survivors.
par: Marjolein van Waas, et autres
Publié: (2012)

Estesioneuroblastoma o neuroblastoma olfatorio
par: Benet M,Sergio, et autres
Publié: (2017)

Neuroblastomas en el niño
par: E,BAUZA, et autres
Publié: (1950)

Neuroblastoma en la infancia
par: del Pozo,H, et autres
Publié: (1976)

Neuroblastoma in an adult: Case report
par: MIRANDA SOARES,PRISCILA BERNARDINA, et autres
Publié: (2010)

IgA Nephropathy Secondary to Ipilimumab Use
par: Sean C. Dougherty, et autres
Publié: (2021)

IMMUNOGLOBULIN A (IgA) AND ITS RECEPTORS
par: V. B. Klimovich, et autres
Publié: (2014)

Deficiencia de IgA: análisis clínico
par: Lamas S,Roger, et autres
Publié: (1976)

IgA nephropathy: A Chinese perspective
par: Zhao Zhang, et autres
Publié: (2021)

A monoclonal antibody to O-acetyl-GD2 ganglioside and not to GD2 shows potent anti-tumor activity without peripheral nervous system cross-reactivity.
par: Nidia Alvarez-Rueda, et autres
Publié: (2011)

Role of Energy Metabolism in the Progression of Neuroblastoma
par: Monika Sakowicz-Burkiewicz, et autres
Publié: (2021)

Kill Your Darlings

EDITORIAL: Killing the messenger
par: David Robie
Publié: (2018)

Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes
par: Ramona Erber, et autres
Publié: (2021)

Crown Ether-Immobilized Cellulose Acetate Membranes for the Retention of Gd (III)
par: Oana Steluta Serbanescu, et autres
Publié: (2021)

Cross-beta nanostructures based on dinaphthylalanine Gd-conjugates loaded with doxorubicin
par: Carlo Diaferia, et autres
Publié: (2017)

Hydroxychloroquine in IgA nephropathy: a systematic review
par: Gabriel Stefan, et autres
Publié: (2021)

Deficiencia selectiva de inmunoglobulina A (IgA)
par: King D,Alexandra, et autres
Publié: (1992)

Pathogenesis of IgA Vasculitis: An Up-To-Date Review
par: Yan Song, et autres
Publié: (2021)

MYCN amplification and ATRX mutations are incompatible in neuroblastoma
par: Maged Zeineldin, et autres
Publié: (2020)

Integrative discovery of treatments for high-risk neuroblastoma
par: Elin Almstedt, et autres
Publié: (2020)

Identification of novel neuroblastoma biomarkers in urine samples
par: Kazuki Yokota, et autres
Publié: (2021)

Restoration of the molecular clock is tumor suppressive in neuroblastoma
par: Myrthala Moreno-Smith, et autres
Publié: (2021)

Monoclonal Antibody Therapies for High Risk Neuroblastoma
par: Furman WL
Publié: (2021)

Neuroblastoma intrarenal mimetizando tumor de Wilms
par: Maria T. Cartaxo Muniz, et autres
Publié: (2005)

Olfactory neuroblastoma managed with endoscopic sinus surgery
par: Saleh Mayoof Al-Osaimi, et autres
Publié: (2021)

NEUROBLASTOMA IN A CASE OF CONGENITAL ADRENAL HYPERPLASIA
par: Arzu Yazal Erdem, et autres
Publié: (2021)

Layer-selective magnetization switching in the chirped photonic crystal with GdFeCo
par: O. V. Borovkova, et autres
Publié: (2021)

DTPAA-Gd Functionalized Ultrasmall Au15NCs Nanohybrids for Multimodal Imaging
par: Wu M, et autres
Publié: (2020)

Gd2O3 nanoparticles in hematopoietic cells for MRI contrast enhancement
par: Hedlund A, et autres
Publié: (2011)

ORDERED L-FUZZY Gd-EXTREMALLY DISCONNECTED SPACES AND TIETZE EXTENSION THEOREM
par: ROJA,E, et autres
Publié: (2008)